Many serious patient illnesses and deaths linked to poor quality compounded drugs have occurred since the 2012 fungal meningitis outbreak. FDA issues compounding risk alerts to communicate information about certain adverse events.
ISMP Newsroom
Safe medication practices depend on communication within the healthcare community, including patients and their families. ISMP is at the forefront of medication error reporting and guidance on safe medication practices, and is often cited in the media as a reputable resource for current information and emerging trends. In 2020, ISMP formally affiliated with ECRI to create one of the largest quality and safety entities in the world. ISMP's Newsroom includes ISMP and ECRI news releases, as well as ISMP blog posts, statements, and other communications.
To schedule an interview or request to be added to ISMP’s news release distribution lists, contact Renee Brehio.
Recent Updates
The FDA monitors reports of adverse events and other problems with medical devices and alerts health professionals and the public when needed to ensure proper use of devices and the health and safety of patients.
The past year has flown by! Before the next year begins, I want to share my experience during my first year as an ISMP fellow.
A study led by ISMP senior scientist Thomas J. Moore and published in JAMA Internal Medicine estimates the costs of pivotal clinical trials that the FDA relies on to prove the benefits of new drugs.
"Unfortunately, I will not be able to present at the 78th FIP World Congress of Pharmacy and Pharmaceutical Sciences, but my student can present on my behalf." My mind started racing. Which student did my mentor mean? Surely not me!
Michael R. Cohen, President of the Institute for Safe Medication Practices (ISMP), has been selected to present ASHP's ninth annual William A. Zellmer Lecture on September 25, 2018.
This article appeared on the Healthcare Packaging website on August 27, 2018.
This article appeared on the Healio website on August 19, 2018.
The Partnership for Health IT Patient Safety, a collaborative that includes ISMP, has issued a new report that identifies ways technology can reduce and eliminate errors from diagnostic testing and medication mix-ups. It is the fourth in a series of safe practices toolkits published by the partnership.
A white paper recently released by ISMP stresses the need for Medication Safety Officers to be included as an integral part of the healthcare team and provides detailed information for hospital leadership on the value of creating a dedicated position directly responsible for and empowered to lead medication safety strategy and implementation.
This article appeared on the Contemporary Pediatrics website on August 2, 2018.
Community pharmacies that have administered AHRQ’s Community Pharmacy Survey on Patient Safety Culture can submit their data to the database October 1 – October 23.
This article appeared in the Philadelphia Inquirer on July 27, 2018.
The International Medication Safety Network (IMSN) and the US Food and Drug Administration (FDA) held a summit for regulators on drug container labeling and packaging safety on June 19 and 20, 2018, to advance global harmonization of standards and reduce overall harm associated with medication errors.
This article appeared on the Healio website on July 19, 2018.
A study published as an online first in JAMA Internal Medicine shows that 77% of patients taking zolpidem (known by the brand names of Ambien, Edluar and Zolpimist), the most widely used prescription sleep medication, were not observing FDA recommendations to promote safe use.
This article appeared on the HealthLeaders website on July 2, 2018.
This article appeared on the Drug Topics website on July 2, 2018.